Drugs / SCNT-hES-RPE Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03305029 | May 2016 → Apr 2019 | dry age related macular degeneration | CHA University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCNT-hES-RPE Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03305029 ↗ |
| Modality | Cell therapy | “SCNT-hES-RPE cellular therapy” NCT03305029 ↗ |
| Route | Other | “Sub-retinal Transplantation” NCT03305029 ↗ |